Cargando…
Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice
The role of IL‐6 signalling in hypertensive heart disease and its sequelae is controversial. Our group demonstrated that Bazedoxifene suppressed IL‐6/gp130 signalling in cancer cells but its effect on myocardial pathology induced by pressure overload is still unknown. We explored whether Bazedoxifen...
Autores principales: | Shi, Wei, Ma, Haiyan, Liu, Tianshu, Yan, Dan, Luo, Pengcheng, Zhai, Maocai, Tao, Jingwen, Huo, Shengqi, Guo, Junyi, Li, Chenglong, Lin, Jiayuh, Zhang, Cuntai, Li, Sheng, Lv, Jiagao, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176848/ https://www.ncbi.nlm.nih.gov/pubmed/32164044 http://dx.doi.org/10.1111/jcmm.15147 |
Ejemplares similares
-
Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice
por: Yan, Dan, et al.
Publicado: (2020) -
Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma
por: Ma, Haiyan, et al.
Publicado: (2019) -
Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene
por: Huo, Shengqi, et al.
Publicado: (2021) -
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019) -
Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)